Navigation Links
Lumenis(R) Introduces Four New Products & Delivery Devices at the 2008 American Academy of Ophthalmology Annual Meeting in Atlanta, Georgia USA
Date:11/6/2008

SANTA CLARA, Calif., Nov. 6 /PRNewswire/ -- Lumenis(R) Ltd. a global developer, manufacturer and marketer of laser, light-based and radiofrequency devices for ophthalmic, surgical and aesthetic applications, announced today that it will introduce four new ophthalmic lasers and delivery devices on November 8th at the American Academy of Ophthalmology (AAO) Annual Meeting in Atlanta, Georgia.

Dov Ofer, Lumenis' President and Chief Executive Officer stated: "Lumenis is proud to be yet again at the forefront of ophthalmic laser technology with the introduction of the Selecta(R) family of ophthalmic lasers, the Novus(R) Spectra(TM) Dual-Port Photocoagulator and the LumeProbe(TM) comprehensive family of premium endo photocoagulation laser probes. This industry-leading achievement stems from Lumenis' 40-year history of ophthalmic laser innovation. In 1970, we were the first company to introduce a laser in this field; since then, we have followed with a series of additional sight-preserving milestones, including the first laser photocoagulator, laser indirect ophthalmoscope, multicolor photocoagulator, photodynamic therapy laser, the revolutionary Selective Laser Trabeculoplasty (SLT) system and solid state multicolor laser."

"At this year's AAO Meeting, we simply continue this long-standing tradition as we proudly showcase the newest additions to our existing and already robust product portfolio of ophthalmic lasers - a new and complete set of ophthalmic laser solutions. Our Selecta family of lasers for the ophthalmic practice offers it all - from ultimate simplicity, to comprehensive choice of therapy with maximum flexibility. Our new laser delivery devices are specifically designed to provide superior performance, as well as improve physician comfort during procedures," said Dov Ofer.

"Today, Lumenis also further expands its capabilities in the Retina segment with the introduction of the LumeProbe product family," said Gideon (Gidi) Sturlesi,
'/>"/>

SOURCE Lumenis Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Lumenis(R) Introduces the Newest Innovations in Fractional CO2 Laser Skin Therapy
2. Lumenis(R) Seeks Shareholder Approval of Proposed Class Action Settlement
3. Delta Dental of Illinois Introduces Smile Smart For Your Health
4. Highmark Blue Cross Blue Shield Introduces New Health Plan Comparison Tool for Consumers
5. Highmark Blue Shield Introduces New Health Plan Comparison Tool for Consumers
6. Sentillion Introduces Affordable Next Generation Healthcare Single Sign-On Solution Called expreSSO(TM)
7. GladRags Introduces the Moon Cup - An Environmentally-Sound and Safe Alternative to Disposable Feminine Hygiene Products!
8. Triveris Introduces Personal Health Record with Built-in Health Advisor
9. Verizon Introduces Broadband Video Call Center Link for Deaf or Hard-of-Hearing Customers in Mid-Atlantic Region
10. Mecklenburg EMS Introduces Most-Advanced Situational Training in America for Emergency Medical Personnel
11. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...9 Sutter Health, a family of docto... service providers, is donating $255,000 to food b...l food banks will share the quarter-million-dollar...les of thousands of families across the north stat...tnering with and supporting charitable programs an...
(Date:11/9/2009)...swire/ -- The Churchill Centre today announced t... J.W. "Bill" Marriott for his lifelong commitment ...rket practices and fostering an open and transpare...ive his award at a ceremony and dinner on Tuesday,...otel. ,, "This is a testament to how Bill Marr...
(Date:11/9/2009)...wswire/ -- Tracy Anderson, trainer to Gwyneth Palt...e hosting two events at her LA studio this week th...ng awaited Nutritional Meal Plan and Delivery Serv...eanse and Lifestyle Menu. She will also be teachi...hod of cardio and muscle structure work. Both eve...
(Date:11/9/2009)...gement, study finds , , MONDAY, Nov. 9 (...for left atrial enlargement, which increases the r...w study shows. , Atrial fibrillation is the mos...ythm or heartbeat). , Researchers analyzed dat...y who were followed for 10 years. The study author...
(Date:11/9/2009)...ing Genetic Variance Across the World is Critical ... (Vocus) November 9, 2009 -- Underst...narily valuable when analyzing and interpreting sc...dy that scanned the genomes of 4,000 people throug...Drs. Chao Tian and Michael F. Seldin of the Univer...
Breaking Medicine News(10 mins):Health News:Sutter Health Donates $255,000 to Help the Hungry This Holiday Season 2Health News:J.W. 'Bill' Marriott to Receive Churchill Centre Award For Leadership 2Health News:Celebrity Trainer Tracy Anderson Sharing Her Fitness and Diet Secrets This Week 2Health News:News from the November/December Issue of Molecular Medicine 2
...tes its 50th anniversary this holiday season, MIN...t,Minneapolis-based Courage Center, announces its ...ard collection. This season, Courage Cards is,cele...Rapids, Wis. -- Nature,s Peace, an,original waterc...
...fit the Cancer Center at Children,s Hospital of ...PHIA, Sept. 8 aloft(SM) hotels, Starwood Hotels,a...festyle brand, which,opened in Philadelphia on 8.8..., A Philadelphia suburb and Havertown native, Han...
... Terrell Samuels, CEO of The,Marketing Doctor LLC,...r,exclusive roster ... fertility specialist Dr. Pe...ls. Dr. Saadat is a well-respected fertility,speci...es, internet, radio, television networks, reality ...
...ildren wielding club while playing away from cours...ay News) -- Although rare, golf-related eye injure...y. , The researchers looked at six boys and five ...ercent) by a golf ball," wrote Dr. Eric M. Hink, o...
...e brain shrinkage, study shows , , MONDAY,...h low levels of vitamin B12 seem to be at increase...esearch suggests. , Brain atrophy is associated wi...levels of B12 actually cause brain atrophy, they...
...The U.S. Department of,Veterans Affairs (VA) annou...g veterans, voter registration activities, with pa...ommunity living centers, domiciliaries and,patient...ups to its hospitals and outpatient clinics to ass...
Other Medicine News:Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 2Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 3Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 4Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 5Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 6Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 7Health News:Courage Cards Announces 2008 Fine Art Holiday Greeting Card Collection 8Health News:aloft(SM) hotels Congratulates Hometown Olympic Swimmer and Gold Medalist Brendan Hansen Friday, September 12, 2008 2Health News:Kids' Eye Injuries From Golf Clubs Rare But Severe 2Health News:Vitamin B12 Key to Aging Brain 2Health News:Vitamin B12 Key to Aging Brain 3Health News:VA Clarifies Voter Registration Regulations 2
(Date:11/9/2009)...v. 9 /PRNewswire-Asia-FirstCall/ -- American Orien...any" or "AOBO"), a pharmaceutical,company dedicate...ufacture and,commercialization of a broad range of...s, today announced that it plans to release third ... 16, 2009, after the market closes. , The...
(Date:11/9/2009)...N.J., Nov. 9 Par Pharmac...ced that it has extended the expiration date and i...unced "Modified Dutch Auction" tender offer, in wh...65,000,000 aggregate principal amount, or up to ap...r Subordinated Convertible Notes due 2010. ,, T...
(Date:11/9/2009)...9, 2009 Arena Pharmaceut...ial results for the third quarter ended September ...locable to common stockholders in the third quarte...mpared to a net loss allocable to common stockhold... or $0.76 per share, and a net loss allocable to c...
Breaking Medicine Technology:Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 2Par Pharmaceutical Announces Extension and Increase in Maximum Purchase Price for 'Modified Dutch Auction' Tender Offer to Purchase up to $65,000,000 Aggregate Principal Amount of its Currently Outstanding 2.875% Senior Subordinated Convertible Note 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 8Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments 9Customers Design Reid Supply 26apos 3Bs New Web Site 50846 1Customers Design Reid Supply 26apos 3Bs New Web Site 50846 2Customers Design Reid Supply 26apos 3Bs New Web Site 50846 3Customers Design Reid Supply 26apos 3Bs New Web Site 50846 4Customers Design Reid Supply 26apos 3Bs New Web Site 50846 5MRI accurately depicts deep endometriosis 50842 1MRI accurately depicts deep endometriosis 50842 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 1SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 2SoundBite 28TM 29 Hearing System by Sonitus Medical Receives First Acceptance for Publication in Otology 26 Neurotology Journal 50838 3
...t and Phase 1b Combination Clinical Trials ...y, SOUTH SAN FRANCISCO, Calif., June 16 Sunesis,...ata Saturday from two,clinical trials of the compa...595), including updated results of a Phase 1 trial...sed or refractory patients with acute,myeloid leuk...
...Pharmaceuticals,Inc. (Amex: ANX ) today provided ... Phase 2b clinical trial of CoFactor for the treat...verall survival results in this,study have been re...fluorouracil) arm demonstrating a 14 day improveme...5-FU arm., "In the Phase 2b study, CoFactor was d...
Other Medicine Technology:Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 2Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 3Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 4Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 5Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association 6ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 2ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results 3
Utility & Splinter Forceps #H
Evisceration Disposible Sizers
Straight Iris Forceps
Semkin Forceps with stops
Medicine Products: